Why DAVI rose 47.3% on Oct 28 2026: ip acquisition
DAVI+47.3%on Wed Oct 28 2026
Davion Healthcare Plc Ordinary Shares was up 47.3% on the day at $4.42, ranked #2 on — its usual five-minute volume, when TapeRank recorded this spike at 04:01 ET during the pre-market session. TapeRank recorded 2 events for DAVI that day, between 04:01 and 08:06 ET, and each is in the timeline below.
THE DAY ON THE LIST · 2 EVENTS
- 04:01 ETMOVER · PRE-MARKET
$4.42 · ▲ 47.3% ON THE DAY · — 5M RVOL · RANK #2
JUSTIFIEDCONFIDENCE5/5DAVI is up 50.3% after announcing completion of its acquisition of WoundSkan and Spektra Lateral Flow Test intellectual property and associated assets. The transaction carries $25 million of stated consideration, including $22.5 million in shares to be issued after a 90-day deferral, making the catalyst material while creating clear future issuance risk.
WHYA 50.3% pre-market move is broadly consistent with a newly completed $25 million healthcare-IP acquisition, though the deferred issuance of 1.73 million shares creates substantial dilution exposure into the move.ANALYZED 04:01 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNATHE ROW AND SESSION LEVELS AT 04:01 ET
LAST4.42DAY▲ 47.3%5 MIN▲ 2.31%5M RVOL—5M $VOL$520KFLOAT—RANK#2SESSIONPRE-MARKETVWAP4.63HOD4.95LOD4.32OR HIGH—OR LOW—PREV CLOSE3.00PM HIGH4.95PM LOW4.32GAP▲ 50.33% (indicated)— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO
- 08:06 ETUNEXPLAINED MOVE · PRE-MARKET
$3.58 · ▲ 19.3% ON THE DAY · 102× 5M RVOL · RANK #12
UNEXPLAINEDNO FILINGS · RULEDAVI is up 20.0% on the day on 91.7x its normal volume for this time of day. No filings or headlines were found in SEC EDGAR filings and Benzinga wire headlines in the last 24 hours, so this is order flow rather than a disclosed catalyst.
WHYNo filings or headlines within 24 hours of the move.ANALYZED 08:06 ET · <1 MIN AGO · RULE, NO MODELTHE ROW AND SESSION LEVELS AT 08:06 ET
LAST3.58DAY▲ 19.3%5 MIN▼ 3.76%5M RVOL102×5M $VOL$450KFLOAT—RANK#12SESSIONPRE-MARKETVWAP4.20HOD4.95LOD3.54OR HIGH—OR LOW—PREV CLOSE3.00PM HIGH4.95PM LOW3.54GAP▲ 22.00% (indicated)— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO
THE SESSION
- 09:30 ETOpened at $3.72, +24.0% on the previous close of $3.00
- 09:31 ETRegular-session high, $3.81
- 11:27 ETRegular-session low, $2.95
- 15:59 ETLast trade of the regular session, $3.23, +7.7% on the previous close of $3.00
- Volume: 2.7M shares in regular hours, 5.3M before the open
DAVI surged before the open, reaching $4.42 and gaining 47.3% as TapeRank tied the move to the announced completion of its acquisition of WoundSkan and Spektra Lateral Flow Test intellectual property and related assets. The $25 million stated consideration included $22.5 million in shares deferred for 90 days, creating future issuance risk, while a later move was marked unexplained because TapeRank found no filings or headlines within 24 hours. The stock opened at $3.72, briefly rose to $3.81, fell to $2.95, and recovered to finish the regular session at $3.23, up 7.7% from the previous close.
WRITTEN WED OCT 28 2026 16:00 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE
FILINGS AND NEWS · 24H BEFORE THE MOVE
- TUE 08:06 ET6-K — Foreign issuer reportSEC 6-K
On the tape right now
WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY
Open the full list